KRAS Cancer Clinical Trial Updates: What Patients Need to Know from ASCO 2025-June G12C Lung NSCLC
1:38:34
YouTubeKRAS Cancer Kickers
KRAS Cancer Clinical Trial Updates: What Patients Need to Know from ASCO 2025-June G12C Lung NSCLC
ASCO stands for the American Society of Clinical Oncology, and every year, it hosts the largest cancer conference in the world. Held in Chicago, the ASCO Annual Meeting brings together tens of thousands of cancer doctors, researchers, advocates, and pharmaceutical leaders to share the latest breakthroughs in cancer care. KRAS Kickers, we follow ...
27.7K views5 months ago
Sotorasib Cancer Treatment
March 15, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)
March 15, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)
YouTubeU.S. Food and Drug
20.4K viewsMar 15, 2024
Sotorasib vs. Adagrasib as Treatment for KRAS G12C Mutated NSCLC - Case Based Panel Discussion
4:13
Sotorasib vs. Adagrasib as Treatment for KRAS G12C Mutated NSCLC - Case Based Panel Discussion
YouTubeGlobal Resource for
872 viewsApr 28, 2023
Sotorasib: Mechanism of Action
0:16
Sotorasib: Mechanism of Action
YouTubeLegacius Pharma
132 views7 months ago
Top videos
What is a KRAS mutation?
1:11
What is a KRAS mutation?
YouTubeAmerican Lung Association
12.7K viewsDec 8, 2020
The Role of KRas in Cancer
3:03
The Role of KRas in Cancer
YouTubeMaja Divjak
3.1K viewsMar 1, 2020
Cancer cell biology: mutated KRAS & reciprocal signalling
2:25
Cancer cell biology: mutated KRAS & reciprocal signalling
YouTubePhospho Biomedical Animatio
32K viewsApr 14, 2016
Sotorasib Clinical Trials
Sotorasib – Mechanism of Action and Synthesis
7:45
Sotorasib – Mechanism of Action and Synthesis
YouTubeOrganic Chemistry with Lluís
2.6K viewsSep 9, 2023
Sotorasib / Lumakras + Panitumumab / Vectibix the Future for KRAS G12C Colorectal Cancer?
Sotorasib / Lumakras + Panitumumab / Vectibix the Future for KRAS G12C Colorectal Cancer?
YouTubeOncologyTube
211 views7 months ago
Sotorasib shows as a tolerable treatment option for patients with KRASG12C-mutated advanced NSCLC
4:19
Sotorasib shows as a tolerable treatment option for patients with KRASG12C-mutated advanced NSCLC
YouTubeecancer
267 viewsMay 16, 2023